GlassScriptPhysician profile
Maria Lijo
NPI 1538129168
$1,013.29
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $154 · 2021: $387 · 2022: $12.03.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $167.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $124.19 | 2019-2021 | |
| Lilly USA, LLC | $105.87 | 2019-2021 | |
| Pfizer INC. | $80.17 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.53 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $72.78 | 2019-2020 | |
| Novo Nordisk INC | $60.47 | 2021 | |
| Allergan, INC. | $52.22 | 2019-2020 | |
| Genentech USA, INC. | $40.99 | 2020-2021 | |
| Amgen INC. | $40.85 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $40.50 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $26.68 | 2021 | |
| Amarin Pharma, INC. | $24.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.48 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $23.15 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.14 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.03 | 2019 | |
| Glaxosmithkline, LLC. | $13.96 | 2019 | |
| Vanda Pharmaceuticals INC. | $11.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lijo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.